Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells (Q57616754)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells	article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

based on heuristic

inferred from title

Antonella Sistigu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Enrico Proietti

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Donatella Negri

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Elena Tritarelli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Michele Equestre

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Cinzia Marcantonio

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Stefano M. Santini

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Caterina Lapenta

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Maurizio Federico

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

M Valentini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

A R Ciccaglione

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

A Costantino

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

S Donati

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

P Tataseo

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

M Miceli

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

0 references

publication date

5 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

3465-3475

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Virus-like particles: passport to immune recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Nucleic acid-independent retrovirus assembly can be driven by dimerization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Particle-based vaccines for HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Occupancy and mechanism in antibody-mediated neutralization of animal viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Neutralization of animal virus infectivity by antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Poxvirus cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Recombinant lentivector as a genetic immunization vehicle for antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Use of viral vectors for the development of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

T-cell immunity generated by recombinant adenovirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Plasmid DNA and viral vector-based vaccines for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

From plasmids to protection: a review of DNA vaccines against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

DNA vaccines: successes and limitations in cancer and infectious disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 G

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Inhibition of human immunodeficiency virus type 1 particle formation by alterations of defined amino acids within the C terminus of the capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Studies in antibody response of mice to tumour inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Identification of H‐2Kb Binding and Immunogenic Peptides from Human Papilloma Virus Tumour Antigens E6 and E7

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

DC contact with HIV-1-infected cells leads to high levels of Env-mediated virion endocytosis coupled with enhanced HIV-1 Ag presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

HIV-1 Nef: at the crossroads

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tails.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Genetic and functional analysis of the human immunodeficiency virus (HIV) type 1-inhibiting F12-HIVnef allele.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Activation of src-family tyrosine kinases by LPS regulates cytokine production in dendritic cells by controlling AP-1 formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

The Lyn tyrosine kinase differentially regulates dendritic cell generation and maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Elicitation of immunity to HIV type 1 Gag is determined by Gag structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Hydrophilicity dependent budding and secretion of chimeric HIV Gag-V3 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Acute hepatitis C virus infection: A chronic problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Immunity to hepatitis C virus: stunned but not defeated

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Dendritic cells transduced with HIV Nef express normal levels of HLA-A and HLA-B class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

The functional consequences of delivery of HIV-1 Nef to dendritic cells using an adenoviral vector.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

High and inducible expression of human immunodeficiency virus type 1 (HIV-1) Nef by adenovirus vector does not disturb potent antigen presentation by monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Novel (n)PKC kinases phosphorylate Nef for increased HIV transcription, replication and perinuclear targeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

Structure and function of hepatitis C virus NS3 helicase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

based on heuristic

inferred from DOI database lookup

Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.059

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.02.059

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21382480%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57616754&oldid=2032422960"